RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis.
Stevens EV, Banet N, Onesto C, Plachco A, Alan JK, Nikolaishvili-Feinberg N, Midkiff BR, Kuan PF, Liu J, Miller CR, Vigil D, Graves LM, Der CJ
Small GTPases. 2011 Jul;2(4):202-210. Epub 2011 Jul 1.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article